Search research articles
Contact Us
Filters
Showing results (201-210 of 216) with videos related to
Page
of 22
Sort By:
Environmental Research
|
October 10, 2023
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies
James Hollister, Alberto J Caban-Martinez, Katherine D Ellingson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 20, 2021
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection
Harmony L Tyner, Jefferey L Burgess, Lauren Grant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2024
Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort Study
James K Romine, Huashi Li, Melissa M Coughlin, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 30, 2021
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021
Karen Lutrick, Patrick Rivers, Young M Yoo, et al.
Diseases (Basel, Switzerland)
|
August 28, 2024
Evaluating Immunologic and Illness Outcomes of SARS-CoV-2 Infection in Vaccinated and Unvaccinated Children Aged ≥ 5 Years, in a Multisite Longitudinal Cohort
Cynthia Porter, Zoe L Lyski, Jennifer L Uhrlaub, et al.
Journal of the Pediatric Infectious Diseases Society
|
December 10, 2024
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023
Leora R Feldstein, Jasmine Ruffin, Ryan Wiegand, et al.
JAMA
|
February 6, 2024
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
Leora R Feldstein, Amadea Britton, Lauren Grant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 29, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses
Meghan K Herring, James K Romine, Meredith G Wesley, et al.
JMIR Research Protocols
|
October 18, 2021
Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study
Laura J Edwards, Ashley L Fowlkes, Meredith G Wesley, et al.
Emerging Infectious Diseases
|
January 26, 2023
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers
Katherine D Ellingson, James Hollister, Cynthia J Porter, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 216) with videos related to
Sort By:
Page
of 22
Environmental Research
|
October 10, 2023
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies
James Hollister, Alberto J Caban-Martinez, Katherine D Ellingson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 20, 2021
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection
Harmony L Tyner, Jefferey L Burgess, Lauren Grant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2024
Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort Study
James K Romine, Huashi Li, Melissa M Coughlin, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 30, 2021
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021
Karen Lutrick, Patrick Rivers, Young M Yoo, et al.
Diseases (Basel, Switzerland)
|
August 28, 2024
Evaluating Immunologic and Illness Outcomes of SARS-CoV-2 Infection in Vaccinated and Unvaccinated Children Aged ≥ 5 Years, in a Multisite Longitudinal Cohort
Cynthia Porter, Zoe L Lyski, Jennifer L Uhrlaub, et al.
Journal of the Pediatric Infectious Diseases Society
|
December 10, 2024
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023
Leora R Feldstein, Jasmine Ruffin, Ryan Wiegand, et al.
JAMA
|
February 6, 2024
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
Leora R Feldstein, Amadea Britton, Lauren Grant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 29, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses
Meghan K Herring, James K Romine, Meredith G Wesley, et al.
JMIR Research Protocols
|
October 18, 2021
Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study
Laura J Edwards, Ashley L Fowlkes, Meredith G Wesley, et al.
Emerging Infectious Diseases
|
January 26, 2023
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers
Katherine D Ellingson, James Hollister, Cynthia J Porter, et al.
Page
of 22